The Need to Avoid a Regulatory Gray Zone in Digital Wellness

This Viewpoint discusses the potential for consumer-facing digital health technologies to influence health-related decisions; highlights the regulatory challenges posed by their increased use; and calls for regulatory standards for these technologies that are evidence-based, transparent, understandable by consumers, and proportionate to potential benefits and harms.

Corresponding Author: John J. Whyte, MD, MPH, American Medical Association, 330 N Wabash Ave, Chicago, IL 60611 (john.whyte@ama-assn.org).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.